RegentAtlantic Capital’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$877K Buy
6,831
+436
+7% +$62.9K 0.03% 337
2022
Q2
$902K Buy
6,395
+719
+13% +$103K 0.03% 336
2022
Q1
$789K Buy
5,676
+271
+5% +$41.5K 0.02% 364
2021
Q4
$942K Buy
5,405
+431
+9% +$71.8K 0.03% 334
2021
Q3
$824K Buy
4,974
+1,586
+47% +$273K 0.02% 335
2021
Q2
$610K Buy
3,388
+485
+17% +$88.5K 0.02% 377
2021
Q1
$560K Buy
2,903
+1,439
+98% +$277K 0.02% 363
2020
Q4
$296K Buy
1,464
+98
+7% +$20.3K 0.01% 424
2020
Q3
$287K Hold
1,366
0.01% 409
2020
Q2
$300K Buy
+1,366
New +$273K 0.02% 387
2015
Q1
Sell
-109
Closed -$11.4K 455
2014
Q4
$11.4K Buy
+109
New +$10.9K ﹤0.01% 880

Other funds holding CLX

RegentAtlantic Capital's CLX Position: Q3 2022 in Review

RegentAtlantic Capital increased its Clorox (CLX) stake by 6.8% in Q3 2022, buying an estimated $62.9K and bringing the position to 6,831 shares worth $877K. The position accounts for 0.03% of the portfolio, ranked #337.

RegentAtlantic Capital first reported a position in CLX in Q4 2014 and has held it in 11 quarters since. The position peaked at $942K in Q4 2021. 1,045 funds tracked by Wall St. Rank hold CLX as of Q3 2022.

  • RegentAtlantic Capital held 6,831 shares of Clorox worth $877K as of Q3 2022.
  • RegentAtlantic Capital bought 436 Clorox shares in Q3 2022, an estimated $62.9K.
  • Clorox made up 0.03% of RegentAtlantic Capital's portfolio in Q3 2022, its #337 holding.
  • RegentAtlantic Capital first reported a position in Clorox in Q4 2014 and has held it in 11 quarters since.
  • RegentAtlantic Capital's Clorox position peaked at $942K in Q4 2021.
  • 1,045 funds tracked by Wall St. Rank held Clorox as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.